VISHNU Vishnu Chemicals Q4 FY25 results (Jan–Mar 2025) and concall
Vishnu Chemicals delivered strong financial performance in Q4 and FY25, achieving record revenues and PAT, driven by robust growth in both Chromium and Barium segments. The company demonstrated improved cash flow and a deleveraged balance sheet, with a debt-to-equity ratio of 0.37x. Strategic investments in backward integration and new chemistries like Strontium Carbonate are expected to drive future growth and margin expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 344 | 371 | 393 |
| EBITDA | 45 | 64 | 64 |
| Net profit | 23 | 34 | 39 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
